BIO-UV Group Balance Sheet Health
Financial Health criteria checks 3/6
BIO-UV Group has a total shareholder equity of €32.9M and total debt of €22.3M, which brings its debt-to-equity ratio to 67.7%. Its total assets and total liabilities are €68.8M and €35.9M respectively. BIO-UV Group's EBIT is €2.0M making its interest coverage ratio 2. It has cash and short-term investments of €3.4M.
Key information
67.7%
Debt to equity ratio
€22.30m
Debt
| Interest coverage ratio | 2x |
| Cash | €3.42m |
| Equity | €32.94m |
| Total liabilities | €35.88m |
| Total assets | €68.83m |
Recent financial health updates
Recent updates
With BIO-UV Group S.A. (EPA:ALTUV) It Looks Like You'll Get What You Pay For
Nov 27
We Think BIO-UV Group (EPA:ALTUV) Is Taking Some Risk With Its Debt
Jun 18Returns On Capital Are Showing Encouraging Signs At BIO-UV Group (EPA:ALTUV)
Mar 16Is There An Opportunity With BIO-UV Group S.A.'s (EPA:ALTUV) 48% Undervaluation?
Dec 02BIO-UV Group (EPA:ALTUV) Is Doing The Right Things To Multiply Its Share Price
Jun 10Need To Know: Analysts Just Made A Substantial Cut To Their BIO-UV Group S.A. (EPA:ALTUV) Estimates
Apr 09Investors Still Waiting For A Pull Back In BIO-UV Group S.A. (EPA:ALTUV)
Jun 16The Return Trends At BIO-UV Group (EPA:ALTUV) Look Promising
Feb 25BIO-UV Group's (EPA:ALTUV) Earnings Are Weaker Than They Seem
Sep 30Returns At BIO-UV Group (EPA:ALTUV) Are On The Way Up
May 22Investors Who Bought BIO-UV Group (EPA:ALTUV) Shares A Year Ago Are Now Up 87%
Jan 11
Is BIO-UV Group S.A. (EPA:ALTUV) Trading At A 48% Discount?
Nov 18Financial Position Analysis
Short Term Liabilities: ALTUV's short term assets (€26.1M) exceed its short term liabilities (€15.5M).
Long Term Liabilities: ALTUV's short term assets (€26.1M) exceed its long term liabilities (€20.4M).
Debt to Equity History and Analysis
Debt Level: ALTUV's net debt to equity ratio (57.3%) is considered high.
Reducing Debt: ALTUV's debt to equity ratio has increased from 25% to 67.7% over the past 5 years.
Debt Coverage: ALTUV's debt is well covered by operating cash flow (31.1%).
Interest Coverage: ALTUV's interest payments on its debt are not well covered by EBIT (2x coverage).
Balance Sheet
Discover healthy companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/02/15 13:10 |
| End of Day Share Price | 2025/02/14 00:00 |
| Earnings | 2024/06/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
BIO-UV Group S.A. is covered by 4 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Stephanie Lefebvre | Gilbert Dupont |
| Martin Tessier | Stifel, Equities Research |
| Martin Tessier | Stifel Europe |